Market Cap

$126.4M

Volume

83.3K

Cash and Equivalents

$21.1M

EBITDA

-$22.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$431.0K

Profit Margin

100.00%

52 Week High

$6.35

52 Week Low

$2.60

Dividend

N/A

Price / Book Value

29.26

Price / Earnings

-7.42

Price / Tangible Book Value

29.26

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$22.9M

Return on Equity

140.34%

Return on Assets

-37.31

Cash and Short Term Investments

$21.1M

Debt

N/A

Equity

$4.3M

Revenue

$431.0K

Unlevered FCF

-$14.2M

Sector

Pharmaceuticals

Category

N/A